Electroacupuncture modulates the gut-brain axis via the PI3K/Akt pathway to improve feeding behavior, body weight, glucolipid metabolism, and reduce insulin resistance in T2DM rats
Authors:
Open Access
- 9 April 2025
- journal article
- research article
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 17 (1) , 1-18
Abstract
The rising prevalence and high mortality of diabetes have made it a significant public health concern. This study explores how electroacupuncture (EA) influences the PI3K/Akt pathway and its role in regulating the gut-brain axis, focusing on whether EA can modulate this axis via the PI3K/Akt pathway in the treatment of type 2 diabetes mellitus (T2DM). The research aims to reveal the mechanisms underlying EA’s therapeutic effects and to investigate a novel strategy for managing T2DM. To induce T2DM in rat models, a high-fat diet and intraperitoneal injection of streptozotocin (STZ) were used. The rats were then randomly divided into four groups: a T2DM group, an EA group, an EA plus PI3K inhibitor group (EA + LY294002), and a control group (Con), which received a standard diet and a citric acid-sodium citrate solution. Following five weeks of intervention, assessments were conducted for food intake, body weight, fasting blood glucose (FBG), blood lipid profiles, and insulin resistance (IR). To analyze the PI3K/Akt pathway and gut-brain axis indices, various methods were employed, including Western blotting, qPCR, immunohistochemistry staining, HE staining, and 16 S rRNA sequencing. Our research shows that EA improves food intake, body weight, FBG, lipid levels (TC, TG, HDL, LDL), serum insulin levels, IR and insulin sensitivity indices in T2DM rats. Additionally, EA boosts the expression of colonic tight junction proteins ZO-1, Occludin, and Claudin-1 while reducing intestinal inflammation and intestinal cell apoptosis. It also regulates Ghrelin and PYY levels in both colonic and hypothalamic tissues, improving the gut microbiota structure. These effects can be reversed by PI3K inhibitors. EA plays a role in managing feeding behavior, body weight, and glucolipid metabolism, as well as alleviating IR in T2DM rats. EA may contribute to the preservation of intestinal mucosal barrier integrity, likely through anti-inflammatory and anti-apoptotic actions mediated by the PI3K/Akt pathway. Additionally, EA appears to influence the regulation of brain-gut peptides and promote a healthier gut microbiota composition. These findings suggest that EA holds potential as an therapeutic approach for T2DM, with its mechanisms potentially linked to the modulation of the gut-brain axis via the PI3K/Akt pathway. Further research is warranted to fully elucidate these effects and their clinical implications.Keywords
Funding Information
- National Natural Science Foundation of China (82474652)
- Natural Science Foundation of Beijing Municipality (7232276)
This publication has 81 references indexed in Scilit:
- The gut–brain axis in appetite, satiety, food intake, and eating behavior: Insights from animal models and human studiesPharmacology Research & Perspectives, 2024
- The PI3K/Akt signaling axis and type 2 diabetes mellitus (T2DM): From mechanistic insights into possible therapeutic targetsCell Biology International, 2024
- Electroacupuncture Improving Intestinal Barrier Function in Rats with Irritable Bowel Syndrome Through Regulating AquaporinsDigestive Diseases and Sciences, 2024
- Gut microbiota and type 2 diabetes mellitus: a focus on the gut-brain axisEndocrine, 2024
- 6‐Shogaol from Dried Ginger Protects against Intestinal Ischemia/Reperfusion by Inhibiting Cell Apoptosis via the BDNF/TrkB/PI3K/AKT PathwayMolecular Nutrition & Food Research, 2023
- Microbiota-gut-brain axis: relationships among the vagus nerve, gut microbiota, obesity, and diabetesActa Diabetologica, 2023
- Electroacupuncture improves cognitive deficits and insulin resistance in an OLETF rat model of Al/D-gal induced aging model via the PI3K/Akt signaling pathwayBrain Research, 2020
- A comparative study of microbial community and functions of type 2 diabetes mellitus patients with obesity and healthy peopleApplied Microbiology and Biotechnology, 2020
- Composite probiotics alleviate type 2 diabetes by regulating intestinal microbiota and inducing GLP-1 secretion in db/db miceBiomedicine & Pharmacotherapy, 2020
- Research progress in the relationship between type 2 diabetes mellitus and intestinal floraBiomedicine & Pharmacotherapy, 2019